330 related articles for article (PubMed ID: 31937764)
1. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
Onwordi EC; Halff EF; Whitehurst T; Mansur A; Cotel MC; Wells L; Creeney H; Bonsall D; Rogdaki M; Shatalina E; Reis Marques T; Rabiner EA; Gunn RN; Natesan S; Vernon AC; Howes OD
Nat Commun; 2020 Jan; 11(1):246. PubMed ID: 31937764
[TBL] [Abstract][Full Text] [Related]
2. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A.
Onwordi EC; Whitehurst T; Shatalina E; Mansur A; Arumuham A; Osugo M; Marques TR; Jauhar S; Gupta S; Mehrotra R; Rabiner EA; Gunn RN; Natesan S; Howes OD
Biol Psychiatry; 2024 Apr; 95(7):639-646. PubMed ID: 37330164
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex.
Halff EF; Cotel MC; Natesan S; McQuade R; Ottley CJ; Srivastava DP; Howes OD; Vernon AC
Behav Brain Res; 2021 May; 405():113203. PubMed ID: 33636238
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the In Vivo Specificity of [
Serrano ME; Becker G; Bahri MA; Seret A; Mestdagh N; Mercier J; Mievis F; Giacomelli F; Lemaire C; Salmon E; Luxen A; Plenevaux A
Molecules; 2019 May; 24(9):. PubMed ID: 31052478
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence of lower synaptic vesicle density in schizophrenia.
Radhakrishnan R; Skosnik PD; Ranganathan M; Naganawa M; Toyonaga T; Finnema S; Hillmer AT; Esterlis I; Huang Y; Nabulsi N; Carson RE; D'Souza DC
Mol Psychiatry; 2021 Dec; 26(12):7690-7698. PubMed ID: 34135473
[TBL] [Abstract][Full Text] [Related]
7. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates.
Li S; Cai Z; Wu X; Holden D; Pracitto R; Kapinos M; Gao H; Labaree D; Nabulsi N; Carson RE; Huang Y
ACS Chem Neurosci; 2019 Mar; 10(3):1544-1554. PubMed ID: 30396272
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain.
Warnock GI; Aerts J; Bahri MA; Bretin F; Lemaire C; Giacomelli F; Mievis F; Mestdagh N; Buchanan T; Valade A; Mercier J; Wood M; Gillard M; Seret A; Luxen A; Salmon E; Plenevaux A
J Nucl Med; 2014 Aug; 55(8):1336-41. PubMed ID: 24935992
[TBL] [Abstract][Full Text] [Related]
10. Synaptic Vesicle Glycoprotein 2A Is Affected in the Central Nervous System of Mice with Huntington Disease and in the Brain of a Human with Huntington Disease Postmortem.
Bertoglio D; Verhaeghe J; Wyffels L; Miranda A; Stroobants S; Mrzljak L; Dominguez C; Skinbjerg M; Bard J; Liu L; Munoz-Sanjuan I; Staelens S
J Nucl Med; 2022 Jun; 63(6):942-947. PubMed ID: 34531262
[TBL] [Abstract][Full Text] [Related]
11. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.
Thomsen MB; Jacobsen J; Lillethorup TP; Schacht AC; Simonsen M; Romero-Ramos M; Brooks DJ; Landau AM
J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280
[TBL] [Abstract][Full Text] [Related]
13. Potential of [
Puuvuori E; Rokka J; Carlsson PO; Li Z; Eriksson J; Eriksson O
Sci Rep; 2021 Dec; 11(1):24466. PubMed ID: 34963683
[TBL] [Abstract][Full Text] [Related]
14. Kinetic evaluation and test-retest reproducibility of [
Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE
J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
[TBL] [Abstract][Full Text] [Related]
15. Exploring with [
Serrano ME; Bahri MA; Becker G; Seret A; Germonpré C; Lemaire C; Giacomelli F; Mievis F; Luxen A; Salmon E; Rogister B; Raedt R; Plenevaux A
Mol Imaging Biol; 2020 Oct; 22(5):1197-1207. PubMed ID: 32206990
[TBL] [Abstract][Full Text] [Related]
16. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study.
Onwordi EC; Whitehurst T; Mansur A; Statton B; Berry A; Quinlan M; O'Regan DP; Rogdaki M; Marques TR; Rabiner EA; Gunn RN; Vernon AC; Natesan S; Howes OD
Transl Psychiatry; 2021 Jul; 11(1):393. PubMed ID: 34282130
[TBL] [Abstract][Full Text] [Related]
17. Quantifying SV2A density and drug occupancy in the human brain using [
Koole M; van Aalst J; Devrome M; Mertens N; Serdons K; Lacroix B; Mercier J; Sciberras D; Maguire P; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895
[TBL] [Abstract][Full Text] [Related]
18. In vivo imaging of synaptic density with [
Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
[TBL] [Abstract][Full Text] [Related]
19. Preclinical PET Studies of [
Thomsen MB; Schacht AC; Alstrup AKO; Jacobsen J; Lillethorup TP; Bærentzen SL; Noer O; Orlowski D; Elfving B; Müller HK; Brooks DJ; Landau AM
Mol Imaging Biol; 2020 Oct; 22(5):1290-1300. PubMed ID: 32514885
[TBL] [Abstract][Full Text] [Related]
20. Validation and noninvasive kinetic modeling of [
Bertoglio D; Verhaeghe J; Miranda A; Kertesz I; Cybulska K; Korat Š; Wyffels L; Stroobants S; Mrzljak L; Dominguez C; Liu L; Skinbjerg M; Munoz-Sanjuan I; Staelens S
J Cereb Blood Flow Metab; 2020 Jun; 40(6):1351-1362. PubMed ID: 31307287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
